Literature DB >> 28246930

Association of Plasma SDF-1 with Bone Mineral Density, Body Composition, and Hip Fractures in Older Adults: The Cardiovascular Health Study.

Laura D Carbone1,2, Petra Bůžková3, Howard A Fink4,5,6,7, John A Robbins8, Monique Bethel1,2, Mark W Hamrick9,10,11,12, William D Hill13,14,15,16.   

Abstract

Aging is associated with an increase in circulating inflammatory factors. One, the cytokine stromal cell-derived factor 1 (SDF-1 or CXCL12), is critical to stem cell mobilization, migration, and homing as well as to bone marrow stem cell (BMSC), osteoblast, and osteoclast function. SDF-1 has pleiotropic roles in bone formation and BMSC differentiation into osteoblasts/osteocytes, and in osteoprogenitor cell survival. The objective of this study was to examine the association of plasma SDF-1 in participants in the cardiovascular health study (CHS) with bone mineral density (BMD), body composition, and incident hip fractures. In 1536 CHS participants, SDF-1 plasma levels were significantly associated with increasing age (p < 0.01) and male gender (p = 0.04), but not with race (p = 0.63). In multivariable-adjusted models, higher SDF-1 levels were associated with lower total hip BMD (p = 0.02). However, there was no significant association of SDF-1 with hip fractures (p = 0.53). In summary, circulating plasma levels of SDF-1 are associated with increasing age and independently associated with lower total hip BMD in both men and women. These findings suggest that SDF-1 levels are linked to bone homeostasis.

Entities:  

Keywords:  Aging; Body composition; Cytokines; DXA; Epidemiology; Osteoporosis

Mesh:

Substances:

Year:  2017        PMID: 28246930      PMCID: PMC5649737          DOI: 10.1007/s00223-017-0245-8

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  42 in total

1.  Differential processing of stromal-derived factor-1alpha and stromal-derived factor-1beta explains functional diversity.

Authors:  Maria De La Luz Sierra; Fuquan Yang; Masashi Narazaki; Ombretta Salvucci; David Davis; Robert Yarchoan; Hongwei H Zhang; Henry Fales; Giovanna Tosato
Journal:  Blood       Date:  2003-10-02       Impact factor: 22.113

2.  Short-chain fatty acids increase expression and secretion of stromal cell-derived factor-1 in mouse and human pre-adipocytes.

Authors:  Venkat N Vangaveti; Catherine Rush; Linda Thomas; Roy R Rasalam; Usman H Malabu; Scott G McCoombe; Richard L Kennedy
Journal:  Hormones (Athens)       Date:  2014-11-05       Impact factor: 2.885

3.  Frailty in older adults: evidence for a phenotype.

Authors:  L P Fried; C M Tangen; J Walston; A B Newman; C Hirsch; J Gottdiener; T Seeman; R Tracy; W J Kop; G Burke; M A McBurnie
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2001-03       Impact factor: 6.053

4.  Age-related CXC chemokine receptor-4-deficiency impairs osteogenic differentiation potency of mouse bone marrow mesenchymal stromal stem cells.

Authors:  Liang G Guang; Adele L Boskey; Wei Zhu
Journal:  Int J Biochem Cell Biol       Date:  2013-06-04       Impact factor: 5.085

5.  Stromal-derived factor-1 promotes the growth, survival, and development of human bone marrow stromal stem cells.

Authors:  Angela Kortesidis; Andrew Zannettino; Sandra Isenmann; Songtao Shi; Tsvee Lapidot; Stan Gronthos
Journal:  Blood       Date:  2005-01-27       Impact factor: 22.113

6.  Socioeconomic status and its association with the risk of developing hip fractures: a region-wide ecological study.

Authors:  Carlen Reyes; Maria García-Gil; Josep Maria Elorza; Francesc Fina-Avilés; Leonardo Mendez-Boo; Eduardo Hermosilla; Ermengol Coma; Cristina Carbonell; Manuel Medina-Peralta; Rafel Ramos; Bonaventura Bolibar; Adolfo Díez-Pérez; Daniel Prieto-Alhambra
Journal:  Bone       Date:  2014-12-24       Impact factor: 4.398

7.  Clinical analysis of systemic and adipose tissue levels of selected hormones/adipokines and stromal-derived factor-1.

Authors:  W Blogowski; K Serwin; M Budkowska; D Salata; B Dolegowska; M Lokaj; P Prowans; T Starzynska
Journal:  J Biol Regul Homeost Agents       Date:  2012 Oct-Dec       Impact factor: 1.711

8.  Diet-induced adiposity alters the serum profile of inflammation in C57BL/6N mice as measured by antibody array.

Authors:  J I Fenton; N P Nuñez; S Yakar; S N Perkins; N G Hord; S D Hursting
Journal:  Diabetes Obes Metab       Date:  2009-04       Impact factor: 6.577

9.  Low-dose bone morphogenetic protein-2/stromal cell-derived factor-1β cotherapy induces bone regeneration in critical-size rat calvarial defects.

Authors:  Samuel Herberg; Cristiano Susin; Manuel Pelaez; R Nicole Howie; Rubens Moreno de Freitas; Jaebum Lee; James J Cray; Maribeth H Johnson; Mohammed E Elsalanty; Mark W Hamrick; Carlos M Isales; Ulf M E Wikesjö; William D Hill
Journal:  Tissue Eng Part A       Date:  2014-02-19       Impact factor: 3.845

10.  Epidemiology of fractures in the United Kingdom 1988-2012: Variation with age, sex, geography, ethnicity and socioeconomic status.

Authors:  Elizabeth M Curtis; Robert van der Velde; Rebecca J Moon; Joop P W van den Bergh; Piet Geusens; Frank de Vries; Tjeerd P van Staa; Cyrus Cooper; Nicholas C Harvey
Journal:  Bone       Date:  2016-03-09       Impact factor: 4.398

View more
  11 in total

Review 1.  What doesn't kill you makes you stranger: Dipeptidyl peptidase-4 (CD26) proteolysis differentially modulates the activity of many peptide hormones and cytokines generating novel cryptic bioactive ligands.

Authors:  Ahmed M Elmansi; Mohamed E Awad; Nada H Eisa; Dmitry Kondrikov; Khaled A Hussein; Alexandra Aguilar-Pérez; Samuel Herberg; Sudharsan Periyasamy-Thandavan; Sadanand Fulzele; Mark W Hamrick; Meghan E McGee-Lawrence; Carlos M Isales; Brian F Volkman; William D Hill
Journal:  Pharmacol Ther       Date:  2019-02-10       Impact factor: 12.310

Review 2.  Stromal cell-derived factor-1 (CXCL12) and its role in bone and muscle biology.

Authors:  William Gilbert; Robert Bragg; Ahmed M Elmansi; Meghan E McGee-Lawrence; Carlos M Isales; Mark W Hamrick; William D Hill; Sadanand Fulzele
Journal:  Cytokine       Date:  2019-07-20       Impact factor: 3.861

3.  Age-associated changes in microRNAs affect the differentiation potential of human mesenchymal stem cells: Novel role of miR-29b-1-5p expression.

Authors:  Nada H Eisa; Periyasamy T Sudharsan; Sergio Mas Herrero; Samuel A Herberg; Brian F Volkman; Alexandra Aguilar-Pérez; Dmitry Kondrikov; Ahmed M Elmansi; Charles Reitman; Xingming Shi; Sadanand Fulzele; Meghan E McGee-Lawrence; Carlos M Isales; Mark W Hamrick; Maribeth H Johnson; Jie Chen; William D Hill
Journal:  Bone       Date:  2021-08-14       Impact factor: 4.398

4.  MicroRNA-141-3p Negatively Modulates SDF-1 Expression in Age-Dependent Pathophysiology of Human and Murine Bone Marrow Stromal Cells.

Authors:  Sudharsan Periyasamy-Thandavan; John Burke; Bharati Mendhe; Galina Kondrikova; Ravindra Kolhe; Monte Hunter; Carlos M Isales; Mark W Hamrick; William D Hill; Sadanand Fulzele
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2019-08-16       Impact factor: 6.053

5.  Bone Turnover Status: Classification Model and Clinical Implications.

Authors:  Alexander Fisher; Leon Fisher; Wichat Srikusalanukul; Paul N Smith
Journal:  Int J Med Sci       Date:  2018-02-01       Impact factor: 3.738

6.  Elevated plasma CXCL12/SDF-1 levels are linked with disease severity of postmenopausal osteoporosis.

Authors:  Xian-Wen Yang; Hong-Xing Huang; Fei Wang; Qi-Lin Zhou; Yan-Qiang Huang; Ru-Zi Qin
Journal:  Innate Immun       Date:  2019-10-22       Impact factor: 2.680

Review 7.  Stromal cell-derived factor-1 as a potential therapeutic target for osteoarthritis and rheumatoid arthritis.

Authors:  Robert Bragg; William Gilbert; Ahmed M Elmansi; Carlos M Isales; Mark W Hamrick; William D Hill; Sadanand Fulzele
Journal:  Ther Adv Chronic Dis       Date:  2019-10-24       Impact factor: 5.091

8.  Serum CXCL12/SDF-1 level is positively related with lumbar intervertebral disc degeneration and clinical severity.

Authors:  Zhao-Juan Er; Chun-Fang Yin; Wen-Jing Wang; Xue-Jun Chen
Journal:  Innate Immun       Date:  2019-12-18       Impact factor: 2.680

9.  Hallmarks of aging-based dual-purpose disease and age-associated targets predicted using PandaOmics AI-powered discovery engine.

Authors:  Frank W Pun; Geoffrey Ho Duen Leung; Hoi Wing Leung; Bonnie Hei Man Liu; Xi Long; Ivan V Ozerov; Ju Wang; Feng Ren; Alexander Aliper; Evgeny Izumchenko; Alexey Moskalev; João Pedro de Magalhães; Alex Zhavoronkov
Journal:  Aging (Albany NY)       Date:  2022-03-29       Impact factor: 5.682

10.  Age-related increase of kynurenine enhances miR29b-1-5p to decrease both CXCL12 signaling and the epigenetic enzyme Hdac3 in bone marrow stromal cells.

Authors:  Ahmed M Elmansi; Khaled A Hussein; Sergio Mas Herrero; Sudharsan Periyasamy-Thandavan; Alexandra Aguilar-Pérez; Galina Kondrikova; Dmitry Kondrikov; Nada H Eisa; Jessica L Pierce; Helen Kaiser; Ke-Hong Ding; Aisha L Walker; Xue Jiang; Wendy B Bollag; Mohammed Elsalanty; Qing Zhong; Xing-Ming Shi; Yun Su; Maribeth Johnson; Monte Hunter; Charles Reitman; Brian F Volkman; Mark W Hamrick; Carlos M Isales; Sadanand Fulzele; Meghan E McGee-Lawrence; William D Hill
Journal:  Bone Rep       Date:  2020-04-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.